Articles

1. Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis

   • Hasan Mushahid
   • Syeda Ayesha Shah
   • Muhammad Shariq Usman

   Systematic Review 29 April 2024

   

2. Cost–Utility Analysis of Vericiguat in Heart Failure with Reduced Ejection Fraction After Worsening Heart Failure Events in China

   • Penglei Chen
   • Yixiang Wang
   • Xuwei Zheng

   Original Research Article 15 April 2024

   

3. Evaluation of the Lifetime Benefits of Metformin and SGLT2 Inhibitors in Type 2 Diabetes Mellitus Patients with Cardiovascular Disease: A Systematic Review and Two-Stage Meta-Analysis

   • Hon Jen Wong
   • Norman H. Lin
   • Ching-Hui Sia

   Systematic Review 08 April 2024

   

4. Trends in Oral Anticoagulant Use and Individual Expenditures Across the United States from 2014 to 2020

   • Omar S. Alkhezi
   • Leo F. Buckley
   • John Fanikos

   Original Research Article 07 April 2024

   

5. Comparative Safety and Efficacy of Low/Moderate-Intensity Statin plus Ezetimibe Combination Therapy vs. High-Intensity Statin Monotherapy in Patients with Atherosclerotic Cardiovascular Disease: An Updated Meta-Analysis

   • Ishaque Hameed
   • Syeda Ayesha Shah
   • Mohammad Hamza

   Original Research Article 05 April 2024

   

6. Authors’ Reply to Rangwala et al: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis”

   • Ioannis Bellos
   • Smaragdi Marinaki
   • Vassiliki Benetou

   Letter to the Editor 04 April 2024

7. Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany

   • Alexander Michel
   • Coralie Lecomte
   • Thomas Evers

   Original Research Article 04 April 2024

   

8. Digoxin is Not Related to Mortality in Patients with Heart Failure: Results from the SELFIE-TR Registry

   • Rengin Çetin Güvenç
   • Tolga Sinan Güvenç
   • Mehmet Birhan Yılmaz

   Original Research Article 04 April 2024

   

9. Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review

   • Hiroaki Hiraiwa
   • Takahiro Okumura
   • Toyoaki Murohara

   Review Article Open access 04 April 2024

   

10. Advancing Guideline-Directed Medical Therapy in Heart Failure: Overcoming Challenges and Maximizing Benefits

    • Zixi Zhang
    • Cancan Wang
    • Qiming Liu

    Review Article Open access 03 April 2024

    

11. Comment on: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis”

    • Hussain Sohail Rangwala
    • Hareer Fatima
    • Burhanuddin Sohail Rangwala

    Letter to the Editor 02 April 2024

12. Efficacy of Intravenous Iron in Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency: A Systematic Review and Meta-Analysis of Randomized Control Trials

    • Andrew Sephien
    • Denisse Camille Dayto
    • Ambuj Kumar

    Systematic Review 22 March 2024 Pages: 285 - 302

    

13. The Rationale for Using Fixed-Dose Combination Therapy in the Management of Hypertension in Colombia: A Narrative Review

    • Dora Inés Molina de Salazar
    • Antonio Coca
    • Daniel Piskorz

    Review Article Open access 15 March 2024 Pages: 197 - 209

    

14. New Perspectives on the Role and Therapeutic Potential of Melatonin in Cardiovascular Diseases

    • Pengchen Gu
    • Yuxin Wu
    • Weiwei Lu

    Review Article 04 March 2024 Pages: 171 - 195

    

15. Acetazolamide as an Adjunctive Diuretic Therapy for Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis

    • Ahmed Kamal Siddiqi
    • Muhammad Talha Maniya
    • Muhammad Shahzeb Khan

    Systematic Review 28 February 2024 Pages: 273 - 284

    

16. Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea

    • Eui-Soon Kim
    • Sun-Kyeong Park
    • Sang Hong Baek

    Original Research Article 27 February 2024 Pages: 313 - 324

    

17. Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic Review and Meta-analysis

    • Mohamed Nabil Elshafei
    • Ahmed El-Bardissy
    • Mohammed Danjuma

    Systematic Review Open access 22 February 2024 Pages: 255 - 271

    

18. Management of Hypertension in the Asia-Pacific Region: A Structured Review

    • Abdul R. A. Rahman
    • Jose Donato A. Magno
    • Rohit Khurana

    Review Article Open access 08 February 2024 Pages: 141 - 170

    

19. Serum Cystatin C as a Risk Factor for Supratherapeutic Digoxin Concentration in Elderly Patients with Heart Failure and Chronic Kidney Disease

    • Jie-Jiu Lu
    • Tao-Tao Liu

    Original Research Article 01 February 2024 Pages: 303 - 311

    

20. Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis

    • Ioannis Bellos
    • Smaragdi Marinaki
    • Vassiliki Benetou

    Systematic Review Open access 01 February 2024 Pages: 241 - 253

    

21. Author’s Reply to Kow et al.: “Comparison of Clinical Outcomes between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study”

    • Hsiu-Yu Fang
    • Wei-Chieh Lee

    Letter to the Editor 25 January 2024 Pages: 327 - 328

22. Comment on: “Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study”

    • Chia Siang Kow
    • Abdullah Faiz Zaihan
    • Syed Shahzad Hasan

    Letter to the Editor 25 January 2024 Pages: 325 - 326

23. SAMe-TT₂R₂ Score to Predict Time in Therapeutic Range of Vitamin K Antagonists in Asian and Non-Asian patients: A Systematic Review and Meta-analysis

    • Natnicha Poonchuay
    • Surasak Saokaew
    • Supatcha Incomenoy

    Systematic Review 22 January 2024 Pages: 211 - 240

    

24. Safety and Efficacy of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors After Acute Coronary Syndrome: A Meta-analysis of Randomized Controlled Trials

    • Ahmed Atia
    • Heba Aboeldahab
    • Ahmed Abdelaziz

    Systematic Review Open access 19 January 2024 Pages: 83 - 102

    

25. Iron Dyshomeostasis and Mitochondrial Function in the Failing Heart: A Review of the Literature

    • Seyed Ali Mousavi-Aghdas
    • Ebrahim Farashi
    • Nasim Naderi

    Review Article 29 December 2023 Pages: 19 - 37

    

26. SGLT2 Inhibitors for Heart Failure with Preserved Ejection Fraction: What Hospitalists Need to Know

    • Stephen J. Greene
    • Gregg C. Fonarow
    • Javed Butler

    Commentary 29 December 2023 Pages: 1 - 4

    

27. The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective

    • Andre Lamy
    • John Eikelboom
    • the COMPASS Investigators

    Original Research Article Open access 28 December 2023 Pages: 117 - 127

    

28. Rivaroxaban Plasma Concentration and Clinical Outcomes on Older Patients with Non-valvular Atrial Fibrillation and Pulmonary Infection

    • Yan Yu
    • Haobin Li
    • Guangchun Sun

    Original Research Article 24 December 2023 Pages: 129 - 139

    

29. Safety and Efficacy of Cangrelor in Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

    • Mostafa Reda Mostafa
    • Mohamed Magdi Eid
    • Andrew M. Goldsweig

    Systematic Review 23 November 2023 Pages: 71 - 81

    

30. The Use of Sodium-Glucose Cotransporter-2 Inhibitors in Coronary Revascularization: Where Are We Now? A Systematic Review

    • Ryaan EL-Andari
    • Nicholas M. Fialka
    • Jeevan Nagendran

    Systematic Review 17 November 2023 Pages: 55 - 69

    

31. A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension

    • Omnia Azmy Nabeh
    • Alaa I. Saud
    • Soha Aly Elmorsy

    Systematic Review Open access 09 November 2023 Pages: 39 - 54

    

32. Acknowledgment to Referees

    ACKNOWLEDGMENT TO REFEREES 31 October 2023 Pages: 595 - 598

33. Intravenous Diltiazem Versus Metoprolol in Acute Rate Control of Atrial Fibrillation/Flutter and Rapid Ventricular Response: A Meta-Analysis of Randomized and Observational Studies

    • Alexander Bolton
    • Bishow Paudel
    • Denice Hodgson-Zingman

    Systematic Review 19 October 2023 Pages: 103 - 115

    

34. Safety and Effectiveness of Apixaban Versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation Stratified by Renal Function: A Retrospective Cohort Study

    • Takeshi Morimoto
    • Haruhiko Hoshino
    • Yukihiro Koretsune

    Original Research Article Open access 17 October 2023 Pages: 721 - 733

    

35. Cardioprotective Strategies After Ischemia–Reperfusion Injury

    • Honghong Zhang
    • Huilin Hu
    • Hongen Tian

    Review Article Open access 10 October 2023 Pages: 5 - 18

    

36. Colchicine for the Prevention of Recurrent Arrhythmia After Catheter Ablation of Atrial Fibrillation: Results of a Single-Center, Retrospective Study

    • Kristen Bova Campbell
    • Stephanie Dougherty Eickman
    • Jonathan P. Piccini

    Original Research Article 06 October 2023 Pages: 709 - 719

    

37. The Current Place of DPP4 Inhibitors in the Evolving Landscape of Type 2 Diabetes Management: Is It Time to Bid Adieu?

    • Theocharis Koufakis
    • Ioanna Zografou
    • Kalliopi Kotsa

    Current Opinion 08 September 2023 Pages: 601 - 608

    

38. Bempedoic Acid can Reduce Cardiovascular Events in Combination with Statins or As Monotherapy: A Systematic Review and Meta-analysis

    • Ju Zhang
    • Xiangfeng Guan
    • Bo Li

    Systematic Review 06 September 2023 Pages: 695 - 708

    

39. The Pivotal Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertension Management and Cardiovascular and Renal Protection: A Critical Appraisal and Comparison of International Guidelines

    • Luis Antonio Alcocer
    • Alfonso Bryce
    • Pablo Rodriguez

    Review Article Open access 05 September 2023 Pages: 663 - 682

    

40. Novel Therapeutic Avenues for Hypertrophic Cardiomyopathy

    • Dipti Patil
    • Lokesh Kumar Bhatt

    Review Article 05 September 2023 Pages: 623 - 640

    

41. Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis

    • Tong Hu
    • Yi-Han Li
    • Jing-Quan Zhong

    Systematic Review 28 August 2023 Pages: 683 - 694

    

42. Double Trouble: The Challenge of Neuroprotection in Patients with Liver Cirrhosis and Atrial Fibrillation

    • Taha Ahmed
    • Adrian W. Messerli

    Commentary 28 August 2023 Pages: 599 - 600

43. SGLT2 Inhibitors in Aging-Related Cardiovascular Disease: A Review of Potential Mechanisms

    • Yali Zhang
    • Yufeng He
    • Jian Feng

    Review Article 24 August 2023 Pages: 641 - 662

    

44. Practical Guidance for the Use of SGLT2 Inhibitors in Heart Failure

    • Ilaria Cavallari
    • Simone Pasquale Crispino
    • Francesco Grigioni

    Review Article 24 August 2023 Pages: 609 - 621

    

45. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    • Jose Seijas-Amigo
    • Mª José Mauriz-Montero
    • Investigadores MEMOGAL

    Original Research Article Open access 23 August 2023 Pages: 583 - 593

    

46. Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study

    • Wei-Chieh Lee
    • Chih-Yuan Fang
    • Hsiu-Yu Fang

    Original Research Article 23 August 2023 Pages: 573 - 581

    

47. Correction: Ticagrelor or Clopidogrel as Antiplatelet Agents in Patients with Chronic Kidney Disease and Cardiovascular Disease: A Meta‑analysis

    • Yinxue Guo
    • Pingyu Ge
    • Lirui Xie

    Correction 18 August 2023 Pages: 737 - 737

48. Ticagrelor or Clopidogrel as Antiplatelet Agents in Patients with Chronic Kidney Disease and Cardiovascular Disease: A Meta-analysis

    • Yinxue Guo
    • Pingyu Ge
    • Lirui Xie

    Systematic Review 02 August 2023 Pages: 533 - 546

    

49. Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy

    • Sneha Annie Sebastian
    • Inderbir Padda
    • Gurpreet Johal

    Review Article 01 August 2023 Pages: 519 - 532

    

50. An Opportune Time to Consider Glucose–Insulin–Potassium Therapy for Takotsubo Syndrome

    • John E. Madias

    Current Opinion 01 August 2023 Pages: 467 - 470